{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:53:01Z","timestamp":1772999581222,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40268-016-0159-3","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T12:26:54Z","timestamp":1481977614000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice"],"prefix":"10.1007","volume":"17","author":[{"given":"Mihail","family":"Boyanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Shinkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Psachoulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Intorcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reneta","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,17]]},"reference":[{"key":"159_CR1","unstructured":"National Institutes of Health. Osteoporosis Overview. In: Osteoporosis and Related Bone Diseases National Resource Center. 2012. http:\/\/www.niams.nih.gov\/Health_Info\/Bone\/Osteoporosis\/overview.pdf . Accessed April 2015."},{"issue":"1\u20132","key":"159_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Ivergard M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1\u20132):136.","journal-title":"Arch Osteoporos."},{"issue":"1\u20132","key":"159_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11657-011-0064-x","volume":"6","author":"AM Borissova","year":"2011","unstructured":"Borissova AM, Rashkov R, Boyanov M, et al. Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50\u00a0years and older. Arch Osteoporos. 2011;6(1\u20132):189\u201395.","journal-title":"Arch Osteoporos."},{"issue":"12","key":"159_CR4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12(12):989\u201395.","journal-title":"Osteoporos Int."},{"issue":"2a","key":"159_CR5","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(97)90021-8","volume":"103","author":"P Lips","year":"1997","unstructured":"Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med. 1997;103(2a):3S\u20138S.","journal-title":"Am J Med."},{"issue":"1\u20132","key":"159_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","volume":"8","author":"A Svedbom","year":"2013","unstructured":"Svedbom A, Hernlund E, Ivergard M, et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8(1\u20132):137.","journal-title":"Arch Osteoporos."},{"issue":"2","key":"159_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00198-006-0211-1","volume":"18","author":"SJ Gallacher","year":"2007","unstructured":"Gallacher SJ, Gallagher AP, McQuillian C, et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int. 2007;18(2):185\u201392.","journal-title":"Osteoporos Int."},{"issue":"5","key":"159_CR8","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1445-5994.2010.02258.x","volume":"42","author":"HJ Teede","year":"2012","unstructured":"Teede HJ, Renouf DA, Jayasuriya IA, et al. STOP fracture study: southern health osteoporotic fracture screening project. Int Med J. 2012;42(5):e74\u20139.","journal-title":"Int Med J."},{"key":"159_CR9","unstructured":"Amgen. Prolia\u00ae summary of product characteristics. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001120\/WC500093526.pdf . Accessed April 2015."},{"issue":"8","key":"159_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756\u201365.","journal-title":"N Engl J Med."},{"issue":"2","key":"159_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2011.03.769","volume":"49","author":"PJ Kostenuik","year":"2011","unstructured":"Kostenuik PJ, Smith SY, Jolette J, et al. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. Bone. 2011;49(2):151\u201361.","journal-title":"Bone."},{"issue":"2","key":"159_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2011.04.001","volume":"49","author":"MS Ominsky","year":"2011","unstructured":"Ominsky MS, Stouch B, Schroeder J, et al. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone. 2011;49(2):162\u201373.","journal-title":"Bone."},{"issue":"1","key":"159_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.536","volume":"27","author":"MR McClung","year":"2012","unstructured":"McClung MR, Boonen S, Torring O, et al. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2012;27(1):211\u20138.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res."},{"issue":"6","key":"159_CR14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/jc.2010-2784","volume":"96","author":"S Boonen","year":"2011","unstructured":"Boonen S, Adachi JD, Man Z, et al. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metabol. 2011;96(6):1727\u201336.","journal-title":"J Clin Endocrinol Metabol."},{"key":"159_CR15","unstructured":"Bone HG, Brandi ML, Brown JP, et al. Ten years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension trial American Society for Bone and Mineral Research 2015 Annual Meeting, 9\u201312 October, Seattle, USA 2015."},{"key":"159_CR16","unstructured":"Borissova AM, Zacharieva S, Boyanov M, et al. Ministry of health: recommendations for good clinical practice in osteoporosis. In: Bulgarian Societies of Endocrinology and Rheumatology. 2013. http:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/National%20Guidelines\/Guideline_Osteoporosis_Bulgaria_2013_abstract.pdf . Accessed Oct 2015."},{"issue":"1","key":"159_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00198-014-2871-6","volume":"26","author":"SL Silverman","year":"2014","unstructured":"Silverman SL, Siris E, Kendler DL, et al. Persistence at 12\u00a0months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study. Osteoporos Int. 2014;26(1):361\u201372.","journal-title":"Osteoporos Int."},{"issue":"2 Suppl","key":"159_CR18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","volume":"122","author":"ES Siris","year":"2009","unstructured":"Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med. 2009;122(2 Suppl):S3\u201313.","journal-title":"Am J Med."},{"issue":"1","key":"159_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","volume":"24","author":"JP Brown","year":"2009","unstructured":"Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res Off J Am Soc Bone Miner Res. 2009;24(1):153\u201361.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res."},{"issue":"8","key":"159_CR20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354(8):821\u201331.","journal-title":"N Engl J Med."},{"issue":"2","key":"159_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375\u201382.","journal-title":"Bone."},{"issue":"1","key":"159_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23\u201357.","journal-title":"Osteoporos Int."},{"key":"159_CR23","unstructured":"Papapoulos S, Lippuner K, Roux C, et al. Eight years of denosumab treatment in postmenopausal women with osteoporosis: results from the first five years of the FREEDOM extension. Osteoporos Int. 2015;24(Suppl 2):Abstr OC21."},{"issue":"4","key":"159_CR24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1532-5415.2010.02769.x","volume":"58","author":"LA Jennings","year":"2010","unstructured":"Jennings LA, Auerbach AD, Maselli J, et al. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010;58(4):650\u20137.","journal-title":"J Am Geriatr Soc."},{"key":"159_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-13-7","volume":"13","author":"AW Kung","year":"2013","unstructured":"Kung AW, Fan T, Xu L, et al. Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study. BMC Womens Health. 2013;13:7.","journal-title":"BMC Womens Health."},{"issue":"4","key":"159_CR26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11845-013-0935-9","volume":"182","author":"B McGowan","year":"2013","unstructured":"McGowan B, Bennett K, Casey MC, et al. Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008. Irish J Med Sci. 2013;182(4):601\u20138.","journal-title":"Irish J Med Sci."},{"issue":"10","key":"159_CR27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2007.01503.x","volume":"37","author":"HJ Teede","year":"2007","unstructured":"Teede HJ, Jayasuriya IA, Gilfillan CP. Fracture prevention strategies in patients presenting to Australian hospitals with minimal-trauma fractures: a major treatment gap. Int Med J. 2007;37(10):674\u20139.","journal-title":"Int Med J."},{"issue":"10","key":"159_CR28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamainternmed.2016.4814","volume":"176","author":"JC Munson","year":"2016","unstructured":"Munson JC, Bynum JW, Bell J, et al. Patterns of prescription drug use before and after fragility fracture. JAMA Int Med. 2016;176(10):1531\u20138.","journal-title":"JAMA Int Med."},{"key":"159_CR29","unstructured":"Borissova AM, Kovatcheva R, Boyanov M, et al. Eastern European and central Asian regional audit\u2014epidemiology costs and burden of osteoporosis in 2010. http:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/Audit%20Eastern%20Europe_Central%20Asia\/Russian_Audit-Bulgaria.pdf . Accessed Oct 2015."},{"key":"159_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/eurpub\/cku119","volume":"25","author":"M Hiligsmann","year":"2015","unstructured":"Hiligsmann M, Ben Sedrine W, Bruyere O, et al. Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Public Health. 2015;25:20\u20135.","journal-title":"Eur J Public Health."},{"issue":"10","key":"159_CR31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","volume":"337","author":"B Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65\u00a0years of age or older. N Engl J Med. 1997;337(10):670\u20136.","journal-title":"N Engl J Med."},{"issue":"1","key":"159_CR32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/GME.0b013e31829be090","volume":"21","author":"JE Manson","year":"2014","unstructured":"Manson JE, Bassuk SS. Calcium supplements: do they help or harm? Menopause. 2014;21(1):106\u20138.","journal-title":"Menopause."},{"key":"159_CR33","doi-asserted-by":"crossref","unstructured":"Papapoulos S, Roux C, Bone HG, et al. Denosumab treatment in postmenopausal women with osteoporosis for up to 9\u00a0years: results through year 6 of the FREEDOM extension. Ann Rhem Dis. 2015;74(Suppl 2).","DOI":"10.1136\/annrheumdis-2015-eular.1097"},{"key":"159_CR34","doi-asserted-by":"crossref","unstructured":"Papapoulos S, Roux C, Bone HG, et al. Denosumab treatment in postmenopausal women with osteoporosis for up to 9\u00a0years: results through year 6 of the FREEDOM extension. Osteoporos Int. 2015;26 (Suppl 1):Abstr OC4.","DOI":"10.1136\/annrheumdis-2015-eular.1097"},{"key":"159_CR35","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00198-015-3164-4","volume":"26","author":"P Hadji","year":"2015","unstructured":"Hadji P, Papaioannou N, Gielen E, et al. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study. Osteoporos Int. 2015;26:2479\u201389.","journal-title":"Osteoporos Int."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-016-0159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-016-0159-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-016-0159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T15:23:13Z","timestamp":1658071393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-016-0159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1007\/s40268-016-0159-3","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,17]]}}}